Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
More and more people are taking weight loss injectables like Wegovy and Mounjaro — and pharmacy experts are worried that not ...
Tori Allen says she’s thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more ...
A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans.
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...
More than 69.2 million FDA-approved weight-loss prescriptions were dispensed in the U.S. from July 2017 through February 2024 ...
The warning comes as demand for weight loss jabs continues to surge, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. They have ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy, to shame. Let's look deeper into these ...